Fair Value Calculator Fair Value Calculator
EN DE

RIBATEX (RIBATEX) Fair Value & Analysis

IN · Market cap ₹815M

R RIBATEX RIBATEX · BSE
Price₹84.46
Fair Value₹131.20
Upside+55.3%
Quality57/100
Watch RIBATEX for free — get notified when fair value or trend changes. Watch for free
Evidence: High Range ₹105.05 – ₹210.46

Fair value as of: Jul 5, 2026

From 21 valuation models · updated today

Share price +33.0% over the past month.

Price vs Fair Value (12 months)

₹90.83 ₹50.18 Fair Value ₹131.20 Jul 2025 Jul 2026

12‑month range ₹50.18 – ₹90.83 · fair‑value band ₹105.05 – ₹210.46 · the ₹84.46 price screens below the ₹131.20 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

RIBATEX (RIBATEX) currently trades at ₹84.46, while our model-based Fair Value estimate is ₹131.20 — implying the stock looks roughly 55.3% undervalued today. We read business quality at 57/100 (solid quality). Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

Over the trailing twelve months, RIBATEX generated revenue of ₹2.6B at a net margin of 3.2%. Revenue declined 11.3% year over year. It earns a return on equity of 8.0%. Net debt stands at ₹717M. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹105.05 (bear case) to ₹210.46 (bull case); at ₹84.46, the current price sits below that range. The share trades about 12% below its 52-week high and 72% above its 52-week low, currently above its 200-day average.

Key figures & financial health

Revenue (TTM) ₹2.6B
Revenue growth (YoY) -11.3%
Net margin 3.2%
Return on equity 8.0%
Free cash flow ₹6.7M FY2026
P/E ratio 10.0
More key figures
Operating margin 7.7%
EPS (TTM) ₹8.42
EPS growth (YoY) +40.7%
Net debt ₹717M FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

RIBATEX reported revenue of ₹2.6B in FY2026 versus ₹2.1B in FY2022, a compound +5.1%/yr. Reported net income was ₹81.3M in FY2026, compounding +13.5%/yr from FY2022.

Revenue +5.1%/yr
FY22 ₹2.1B
FY23 ₹2.2B
FY24 ₹2.2B
FY25 ₹3.0B
FY26 ₹2.6B
Net income +13.5%/yr
FY22 ₹48.9M
FY23 ₹74.0M
FY24 ₹79.2M
FY25 ₹85.0M
FY26 ₹81.3M

Is RIBATEX fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "RIBATEX Fair Value". https://www.fairvalue-calculator.com/stock/RIBATEX

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is RIBATEX (RIBATEX) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹131.20 versus a price of ₹84.46 — about +55% (undervalued). Model-based estimate, not financial advice.
What is the fair value of RIBATEX?
Our model-based fair value for RIBATEX is ₹131.20 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹84.46.
What is the quality score of RIBATEX?
RIBATEX has a Quality Score of 57/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of RIBATEX (RIBATEX)?
RIBATEX reported trailing-twelve-month revenue of about ₹2.6B (latest available figure, as of Jul 5, 2026).
What is the net profit margin of RIBATEX?
The net profit margin of RIBATEX is about 3.2%, meaning it keeps roughly 3.2% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.